Advanced Biofuels


Amyris Names Raffi Asadorian as Chief Financial Officer Beginning Jan. 6, 2015

Date Posted: December 3, 2014

Emeryville, Calif., Dec. 3, 2014 — Amyris, Inc. (Nasdaq:AMRS) announced today the appointment of Raffi Asadorian as the Company's Chief Financial Officer, effective January 6, 2015.

The Company's interim Chief Financial Officer, Paulo Diniz, will transition to a new role as Chairman of Amyris Brasil.

"Raffi's global finance and business leadership experience will be valuable to Amyris as we enter a new growth phase leveraging our stable and low cost manufacturing and advantaged technology platform to strengthen our leading position in the emerging industrial biotechnology industry," said John Melo, President & Chief Executive Officer of Amyris, Inc.

"Paulo Diniz, who led our global finance operations on an interim basis since earlier this year, will work closely with Raffi during the transition period and then take on a new role as Chairman of our Brazilian operations."

"As we complete two years of successful manufacturing operations at our Brotas biorefinery, we are focused on our increasing product demands as well as expanding our collaboration portfolio in Brazil."

"As Chairman of Amyris Brasil, Paulo is ideally suited to lead us into a new growth phase in Brazil with our strong team there and in the United States," Melo concluded.

Prior to joining Amyris, Mr. Asadorian was the Chief Financial Officer at Unilabs, a private equity-owned medical diagnostics company based in Switzerland.

Previously, he held a senior executive finance role at Barr Pharmaceuticals and was a Partner at PricewaterhouseCoopers, in its Transaction Services (mergers and acquisitions advisory) group.

"This is an exciting time to be joining Amyris and its talented team. The Company is well positioned, and I look forward to supporting the next phase of growth and continued execution of its business strategy."

I am confident that, with Paulo's support, we will ensure a seamless transition in the leadership of the finance function," said Raffi Asadorian.

For more information, please contact Joel Velasco at 1-510-740-7481.

See Related Websites/Articles:

more ADVANCED BIOFUELS...